Relate
Raptiva |
| |
|
Raptiva is a medicine used to treat adult patients with moderate to severe plaque psoriasis whose psoriasis is appropriate for treatment with whole body (systemic therapy) or phototherapy. Raptiva has not been studied in children under 18 years of age.
|
Psoriasis is a chronic (long-lasting) skin disease of scaling and inflammation that affects 2 to 2.6 percent of the United States population, or between 5.8 and 7.5 million people. Although the disease occurs in all age groups, it primarily affects adults. It appears about equally in males and females. Psoriasis occurs when skin cells quickly rise from their origin below the surface of the skin and pile up on the surface before they have a chance to mature. Usually this movement (also called tur...
|
Efalizumab as related to Psoriasis
- Efalizumab (Raptiva) – drug class, medical uses, medication side ...
Explains the medication Efalizumab (Raptiva) a drug used for the treatment of moderate to severe plaque psoriasis. Article includes descriptions, uses, drug ...
- Raptiva Efalizumab for psoriasis.
Raptiva Efalizumab is a powerful drug for psoriasis treatment with many side effects. ... Raptiva Efalizumab. Dangers of Steroids. Skincap dangers. Enbrel ...
- Raptiva (Efalizumab)
Treatment for adults with chronic moderate to severe plaque psoriasis. By Genentech.
- BioMed Central | Full text | Evaluation of efalizumab using safe ...
... the multidimensional effect that efalizumab has in safely controlling psoriasis. ... the Safe Psoriasis Control approach to efalizumab clinical trial data. ...
- Treatment: Biologics - Efalizumab
... about the biologic known by the generic name of efalizumab ... receiving long-term efalizumab therapy for psoriasis have developed psoriatic arthritis. ...
- NEJM -- A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis
Original Article from The New England Journal of Medicine -- A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis
- Psoriasis Treatment and Effectiveness - RAPTIVA (efalizumab)
RAPTIVA is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy ...
- MedlinePlus Drug Information: Efalizumab Injection
Efalizumab is used to treat chronic (long-lasting) plaque psoriasis (a skin ... Try to inject efalizumab in skin that is free of symptoms of psoriasis. ...
- Etanercept and efalizumab for the treatment of adults with psoriasis.
Etanercept and efalizumab for the treatment of adults with psoriasis. BIBLIOGRAPHIC SOURCE(S) ... etanercept and efalizumab in moderate to severe psoriasis, a ...
- Rebound of psoriasis during treatment with efalizumab | Journal of ...
Rebound of psoriasis during treatment with efalizumab from Journal of Drugs in Dermatology in Health provided free by Find Articles.
- PsoriasisTx.com - Psoriasis Meetings and Links
Find reports on psoriasis from recent meetings, a calendar of upcoming meetings, ... Sobell J, Fretzin S. Case studies of efalizumab in hand and foot psoriasis. ...
- Psoriasis: More Than Cosmetic
Psoriasis can be physically and emotionally painful for the ... Raptiva (efalizumab), made by Genentech Inc.; and Enbrel (etanercept), marketed by Amgen Inc. ...
- News Headlines: Psoriasis
... Risk of Psoriasis. Efalizumab Is Safe For Long-Term Use in Psoriasis Patients ... agent efalizumab (Raptiva) to treat chronic plaque psoriasis – a chronic ...
- The long-term efficacy and safety of new biological therapies for psoriasis
... Alefacept, Efalizumab, Etanercept, Infliximab, Long-term treatment, Psoriasis ... efalizumab therapy in patients with moderate to severe chronic plaque psoriasis ...
- Efalizumab for Psoriasis May Trigger Psoriatic Arthritis
Results of a study published in the June issue of Arthritis and Rheumatism suggest that treatment with efalizumab for moderate to severe psoriasis may trigger ...
- Psoriasis: Biological Therapies
... infusions of efalizumab (Emab) in 39 patients with moderate-to-severe psoriasis. Efalizumab was administered for 7 weeks at doses of 0.1 mg/kg every other week ...
- Treatment of Hand and Foot Psoriasis with Emphasis on Efalizumab
Hand and foot psoriasis is a chronic and debilitating disease that manifests as plaque-type or pustular-type lesions. Recent evidence indicates that efalizumab, an ...
- BioMed Central | Full text | Psoriasis vulgaris flare during efalizumab ...
Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series ... psoriasis flare while on a saturating dose of efalizumab ...
- Efalizumab NME Monograph
plaque psoriasis who are candidates for systemic therapy or phototherapy. Efalizumab does not ... Efalizumab for the Treatment of Chronic Plaque Psoriasis, FDA ...
- PsoriasisTx.com - PsoriasisTx Expert Practice
PsoriasisTx provide reports by experts in the treatment of psoriasis. ... events, and the use of efalizumab in special populations of psoriasis patients. ...

Not Signed In -


